NASDAQ : SDGR
Schrödinger, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 27.14 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.03B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.96B |
| Enterprise Value | 1.65B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 65.64M |
| Shares Outstanding | 74.81M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | +2.41% |
| Owned by Insiders (%) | 2.53% |
| Owned by Institutions (%) | 89.10% |
| Float | 57.33M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.69 |
| Forward PS | 8.44 |
| PB Ratio | 6.01 |
| P/TBV Ratio | 6.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 6.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.71 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -16.18% |
| Return on Assets (ROA) | -14.44% |
| Return on Invested Capital (ROIC) | -684.76% |
| Return on Capital Employed (ROCE) | -32.89% |
| Weighted Average Cost of Capital (WACC) | 12.66% |
| Revenue Per Employee | $304,747 |
| Profits Per Employee | -$63,924 |
| Employee Count | 850 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.40M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.65 |
| 52-Week Price Change | +25.38% |
| 50-Day Moving Average | 25.09 |
| 200-Day Moving Average | 16.80 |
| Relative Strength Index (RSI) | 50.84 |
| Average Volume (20 Days) | 2,091,836 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10.40M |
| Short Previous Month | 10.13M |
| Short % of Shares Out | 13.91% |
| Short % of Float | 18.14% |
| Short Ratio (days to cover) | 3.16 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 259.04M |
| Gross Profit | 147.31M |
| Operating Income | -153.45M |
| Pretax Income | -51.93M |
| Net Income | -54.34M |
| EBITDA | -147.58M |
| EBIT | -153.45M |
| Loss Per Share | -$0.74 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 413.74M |
| Total Debt | 108.00M |
| Net Cash | 305.74M |
| Net Cash Per Share | $4.09 |
| Equity (Book Value) | 328.96M |
| Book Value Per Share | 4.51 |
| Working Capital | 296.63M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -126.87M |
| Capital Expenditures | -3.40M |
| Depreciation & Amortization | 5.87M |
| Net Borrowing | -58,000 |
| Free Cash Flow | -130.27M |
| FCF Per Share | -$1.74 |
Margins
| Measure | Value |
|---|
| Gross Margin | 56.87% |
| Operating Margin | -59.24% |
| Pretax Margin | -20.05% |
| Profit Margin | -20.98% |
| EBITDA Margin | -56.97% |
| EBIT Margin | -59.24% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.31% |
| Shareholder Yield | -1.31% |
| Earnings Yield | -2.82% |
| FCF Yield | -6.54% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $25.86 |
| Price Target Difference | -1.26% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 4.42% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.04 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |